RxDoctor Payments Data

Aravind Kalluri

Cardiovascular Disease · Chicago, ILNPI 1184179335

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (30.9%), grants and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Biosense Webster, Inc. at 31.6% of the total. 2025 is the largest year on record at $26,426, more than ten times the $37 reported in 2023. Among cardiovascular disease clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,117in general payments, 2019–2025

Across 119 payments — averaging $244.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$9K
  • Abbott$7K
  • Boston Scientific$6K
  • Medtronic$6K
  • Amgen$149
  • Biotronik Inc.$104
  • plus $346 from 9 others

What the payments were for

  • Consulting fees$9,00031%
  • Grants$8,54529%
  • Travel & lodging$4,86117%
  • Food & beverage$6,13621%
  • Education$5742%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,117 in reported general payments places this provider in the 90th percentile of 932 cardiovascular disease providers in Illinois.

See all cardiovascular disease providers in Illinois →

Other cardiovascular disease in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →